Skip to content

Food and Drugs Act

R.S.C., 1985, c. F-27

In forceCurrent to September 30, 2026 History

Loading…

Part II — Administration and Enforcement

Inspection, Seizure and Forfeiture

Marginal note:Inspectors

  •  (1) For the purposes of the administration and enforcement of this Act, the Minister may designate individuals or classes of individuals as inspectors to exercise powers or perform duties or functions in relation to any matter referred to in the designation.

  • Marginal note:Certificate to be produced

    (2) An inspector shall be given a certificate in a form established by the Minister or the President of the Canadian Food Inspection Agency attesting to the inspector’s designation and, on entering any place pursuant to subsection 23(1), an inspector shall, if so required, produce the certificate to the person in charge of that place.

  • R.S., 1985, c. F-27, s. 22
  • 1997, c. 6, s. 63
  • 2016, c. 9, s. 4
.

Marginal note:Provision of documents, information or samples

  •  (1) An inspector may, for a purpose related to verifying compliance or preventing non-compliance with the provisions of this Act or the regulations, order a person to provide, on or before the date and time specified by the inspector and at the place and in the manner specified by the inspector, any document, information or sample specified by the inspector.

  • Marginal note:Duty to provide

    (2) A person that is ordered by an inspector to provide a document, information or a sample shall do so on or before the date and time, and at the place and in the manner, specified by the inspector.

  • 2019, c. 29, s. 170
.

Marginal note:Powers of inspectors

  •  (1) Subject to subsection (9), an inspector may, for a purpose related to verifying compliance or preventing non-compliance with the provisions of this Act or the regulations, enter any place, including a conveyance, in which they believe on reasonable grounds

    • (a) an activity that may be regulated under this Act is being conducted;

    • (b) any article to which this Act or the regulations apply is located;

    • (c) an activity could be conducted under an authorization, including a licence, for which an application is under consideration by the Minister; or

    • (d) an activity could be conducted as a result of an exemption that is under consideration by the Minister.

  • Marginal note:Other powers

    (2) The inspector may, in the place entered under subsection (1),

    • (a) examine any article to which this Act or the regulations apply or anything that the inspector believes on reasonable grounds is used or is capable of being used for an activity regulated under this Act;

    • (b) open and examine any receptacle or package that the inspector believes on reasonable grounds contains any article to which this Act or the regulations apply;

    • (c) examine — and make copies of or take extracts from — any record, report, electronic data or other document that is found at the place and that the inspector believes on reasonable grounds includes information relevant to the administration of this Act or the regulations;

    • (d) cause to be reproduced any electronic data referred to in paragraph (c);

    • (e) use, or cause to be used, any computer system or telecommunication system at the place;

    • (f) examine — and reproduce or cause to be reproduced — any electronic data that is contained in or available to a system referred to in paragraph (e) and that the inspector believes on reasonable grounds includes information relevant to the administration of this Act or the regulations;

    • (g) remove, for examination or copying, any copies made or extracts taken under paragraph (c), (d) or (f);

    • (h) test anything that the inspector believes on reasonable grounds is an article to which this Act or the regulations apply;

    • (i) take samples of any food, drug, cosmetic, device or anything used for an activity regulated under this Act;

    • (j) take photographs and make recordings and sketches;

    • (k) remove anything from the place for the purpose of examination, conducting tests or taking samples; and

    • (l) seize and detain for the time that may be necessary any article that the inspector believes on reasonable grounds is an article by means of, or in relation to which, any provision of this Act or the regulations has been contravened.

  • Marginal note:Means of telecommunication

    (3) For the purposes of subsection (1), an inspector is considered to have entered a place when they access it remotely by a means of telecommunication.

  • Marginal note:Limitation — access by means of telecommunication

    (4) An inspector who enters remotely, by a means of telecommunication, a place that is not accessible to the public shall do so with the knowledge of the owner or person in charge of the place and only for the period necessary for the purpose referred to in subsection (1).

  • Marginal note:Stopping or moving conveyance

    (5) For the purpose of entering a conveyance, an inspector may order the owner or person having possession, care or control of the conveyance to stop it or move it.

  • Marginal note:Duty to comply

    (6) An owner or person who, under subsection (5), is ordered to stop or move a conveyance shall stop or move it.

  • Marginal note:Individual accompanying inspector

    (7) An inspector may be accompanied by any other individual that the inspector believes is necessary to help them exercise their powers or perform their duties or functions under this section.

  • Marginal note:Entering private property

    (8) An inspector and any individual accompanying them may enter and pass through private property, other than a dwelling-house on that property, in order to gain entry to a place referred to in subsection (1). For greater certainty, they are not liable for doing so.

  • Marginal note:Warrant to enter dwelling-house

    (9) In the case of a dwelling-house, an inspector may enter it only with the consent of the occupant or under the authority of a warrant issued under subsection (10).

  • Marginal note:Authority to issue warrant

    (10) A justice of the peace may, on ex parte application, issue a warrant authorizing the inspector named in it to enter a dwelling-house, subject to any conditions specified in the warrant, if the justice is satisfied by information on oath that

    • (a) the dwelling-house is a place referred to in subsection (1);

    • (b) entry to the dwelling-house is necessary for a purpose referred to in that subsection; and

    • (c) entry to the dwelling-house has been refused or there are reasonable grounds to believe that it will be refused.

  • Marginal note:Use of force

    (11) In executing a warrant issued under subsection (10), an inspector shall not use force unless they are accompanied by a peace officer and the use of force is specifically authorized in the warrant.

  • Marginal note:Means of telecommunication

    (12) An application for a warrant under subsection (10) may be submitted, and the warrant may be issued, by a means of telecommunication and section 487.1 of the Criminal Code applies for those purposes with any necessary modifications.

  • Marginal note:Assistance to inspector

    (13) The owner or other person in charge of a place entered by an inspector under subsection (1) and every individual found there shall

    • (a) give the inspector all reasonable assistance; and

    • (b) provide the inspector with any information that the inspector may reasonably require, including information that is necessary to establish their identity to the inspector’s satisfaction.

  • Marginal note:Definition of article to which this Act or the regulations apply

    (14) In subsections (1) and (2), article to which this Act or the regulations apply includes

    • (a) any food, drug, cosmetic or device;

    • (b) anything used for an activity regulated under this Act; and

    • (c) any record, report, electronic data or other document — including any labelling or advertising material — relating to the administration of this Act or the regulations.

  • R.S., 1985, c. F-27, s. 23
  • R.S., 1985, c. 31 (1st Supp.), s. 11, c. 27 (3rd Supp.), s. 2
  • 2019, c. 29, s. 170
  • 2022, c. 17, s. 63
  • 2024, c. 17, s. 323
.

Marginal note:Obstruction and false statements

  •  (1) No person shall obstruct or hinder, or knowingly make any false or misleading statement either orally or in writing to, an inspector while the inspector is engaged in carrying out his duties or functions under this Act or the regulations.

  • Marginal note:Interference

    (2) Except with the authority of an inspector, no person shall remove, alter or interfere in any way with anything seized under this Part.

  • R.S., c. F-27, ss. 22, 37
.

Marginal note:Storage, movement and disposal

 An inspector may, in respect of any article seized under this Part,

  • (a) on notice to its owner or the person having possession, care or control of it at the time of its seizure, store it or move it at the expense of the person to whom the notice is given;

  • (b) order its owner or the person having possession, care or control of it at the time of its seizure to store it or move it at the expense of the person being so ordered; or

  • (c) order its owner or the person having possession, care or control of it at the time of its seizure to dispose of it at the expense of the person being so ordered — or, on notice to its owner or the person having possession, care or control of it at the time of its seizure, dispose of it at the expense of the person to whom the notice is given — if

    • (i) the article is perishable, or

    • (ii) the inspector is of the opinion that the article presents a risk of injury to health or safety and that its disposal is necessary to respond to the risk.

  • R.S., 1985, c. F-27, s. 25
  • 2016, c. 9, s. 5
.

Marginal note:Release of seized articles

 An inspector who has seized any article under this Part shall release it when he is satisfied that all the provisions of this Act and the regulations with respect thereto have been complied with.

  • R.S., c. F-27, ss. 23, 37
.

Marginal note:Unclaimed seized articles

  •  (1) An article seized under this Part is, at the election of the Minister or the Minister of Agriculture and Agri-Food, forfeited to Her Majesty in right of Canada if

    • (a) within 60 days after the seizure, no person is identified in accordance with the regulations, if any, as its owner or as the person entitled to possess it; or

    • (b) its owner or the person having possession, care or control of it at the time of its seizure does not claim it within 60 days after the day on which they are notified that an inspector has released it.

  • Marginal note:Disposal

    (2) A seized article that is forfeited under subsection (1) may be disposed of, as the Minister or the Minister of Agriculture and Agri-Food may direct, at the expense of its owner or the person having possession, care or control of it at the time of its seizure.

  • 2016, c. 9, s. 6
.

Marginal note:Forfeiture with consent

  •  (1) If an inspector has seized an article under this Part and its owner or the person having possession, care or control of it at the time of its seizure consents to its forfeiture, the article is forfeited to Her Majesty in right of Canada and may be disposed of as the Minister or the Minister of Agriculture and Agri-Food may direct, at the expense of its owner or the person having possession, care or control of the article at the time of its seizure.

  • Marginal note:Forfeiture — offence

    (2) If a person has been convicted of a contravention of this Act or the regulations, the court or judge may, in addition to any punishment imposed, order that any article by means of or in relation to which the offence was committed, and any thing of a similar nature belonging to or in the possession, care or control of the person or found with the article, be forfeited. On the making of the order, the article and thing are forfeited to Her Majesty in right of Canada and may be disposed of as the Minister or the Minister of Agriculture and Agri-Food may direct, at the expense of the person who has been convicted.

  • Marginal note:Order for forfeiture on application of inspector

    (3) Without prejudice to subsection (2), a judge of a superior court of the province in which any article is seized under this Part may, on the application of an inspector and on any notice to those persons that the judge directs, order that the article and any thing of a similar nature found with it be forfeited to Her Majesty in right of Canada, if the judge finds, after making any inquiry that the judge considers necessary, that the article is one by means of or in relation to which a provision of this Act or the regulations has been contravened. On the making of the order, the article or thing may be disposed of as the Minister or the Minister of Agriculture and Agri-Food may direct, at the expense of the owner of the article or the person having possession, care or control of it at the time of its seizure.

  • R.S., 1985, c. F-27, s. 27
  • 1992, c. 1, s. 145(F)
  • 1994, c. 38, s. 19
  • 1995, c. 1, s. 62
  • 1996, c. 8, s. 23.2
  • 1997, c. 6, s. 64
  • 2016, c. 9, s. 6
.

Removal, Forfeiture or Destruction of Unlawful Imports

Marginal note:Unlawful imports

  •  (1) An inspector who has reasonable grounds to believe that an imported food, drug, cosmetic or device does not meet the requirements of the regulations or was imported in contravention of a provision of this Act or the regulations may decide whether to give the owner or importer, or the person having possession, care or control of the food, drug, cosmetic or device, the opportunity to take a measure in respect of it.

  • Marginal note:Factors

    (2) In making a decision under subsection (1), the inspector shall consider, among other factors:

    • (a) whether the food, drug, cosmetic or device presents a risk of injury to health or safety; and

    • (b) any other prescribed factors.

  • Marginal note:Duty of inspector

    (3) If the inspector decides under subsection (1) not to give the owner or importer, or the person having possession, care or control of the food, drug, cosmetic or device the opportunity to take a measure in respect of it, the inspector shall exercise, in respect of the food, drug, cosmetic or device, any of the powers conferred by the provisions of this Act, other than this section, or of the regulations.

  • Marginal note:Measures that may be taken and notice

    (4) However, if the inspector decides under subsection (1) to give the owner or importer, or the person having possession, care or control of the food, drug, cosmetic or device the opportunity to take a measure in respect of it, the inspector, or any other inspector who is informed of the decision, shall decide whether the owner or importer, or the person having possession, care or control of it may remove it from Canada at their expense, consent to its forfeiture or take either of these measures, and shall notify or cause to be notified the owner or importer, or the person having possession, care or control of the food, drug, cosmetic or device that they may take that measure within the period specified by the inspector or other inspector, as the case may be.

  • Marginal note:Forfeiture

    (5) If a person is notified under subsection (4) that they may consent to the forfeiture of the food, drug, cosmetic or device and the person consents to its forfeiture, the food, drug, cosmetic or device is forfeited to Her Majesty in right of Canada and may be disposed of, as the Minister may direct, at the person’s expense.

  • 2016, c. 9, s. 6
.

Marginal note:Removal or destruction

  •  (1) An inspector who has reasonable grounds to believe that an imported food, drug, cosmetic or device does not meet the requirements of the regulations or was imported in contravention of a provision of this Act or the regulations may, by notice, whether the food, drug, cosmetic or device is seized or not, order its owner or importer, or the person having possession, care or control of it, to remove it from Canada at their expense or, if removal is not possible, to destroy it at their expense.

  • Marginal note:Notice

    (2) The notice must be delivered personally to the owner or importer of the food, drug, cosmetic or device, or the person having possession, care or control of it, or sent to the owner, importer or person by any method that provides proof of delivery or by any prescribed method.

  • Marginal note:Forfeiture

    (3) If the food, drug, cosmetic or device is not removed from Canada, or destroyed, within the period specified in the notice — or, if no period is specified, within 90 days after the day on which the notice was delivered or sent — it is, despite section 26, forfeited to Her Majesty in right of Canada and may be disposed of, as the Minister may direct, at the expense of the person to whom the notice was delivered or sent.

  • Marginal note:Suspension of application of subsection (3)

    (4) An inspector may, for the period specified by the inspector, suspend the application of subsection (3) if the inspector is satisfied that

    • (a) the food, drug, cosmetic or device does not present a risk of injury to health;

    • (b) the food, drug, cosmetic or device will not be sold within that period;

    • (c) the measures that should have been taken for the food, drug, cosmetic or device not to have been imported in contravention of a provision of this Act or the regulations will be taken within that period; and

    • (d) if the food, drug, cosmetic or device does not meet the requirements of the regulations, it will be brought into compliance with those requirements within that period.

  • Marginal note:Cancellation

    (5) An inspector may cancel the notice if the inspector is satisfied that

    • (a) the food, drug, cosmetic or device does not present a risk of injury to health;

    • (b) the food, drug, cosmetic or device has not been sold within the period referred to in subsection (6);

    • (c) the measures referred to in paragraph (4)(c) were taken within that period; and

    • (d) if the food, drug, cosmetic or device did not meet the requirements of the regulations when it was imported, it was brought into compliance with those requirements within that period.

  • Marginal note:Period

    (6) The period for the purposes of subsection (5) is

    • (a) if the application of subsection (3) was suspended under subsection (4), the period of the suspension; and

    • (b) if the application of subsection (3) was not suspended, the period specified in the notice or, if no period was specified, the period of 90 days after the day on which the notice was delivered or sent.

  • Marginal note:Non-application of Statutory Instruments Act

    (7) The Statutory Instruments Act does not apply to the notice.

  • 2016, c. 9, s. 6
.

Preventive and Remedial Measures

Marginal note:Measures

  •  (1) If the Minister has reasonable grounds to believe that a person has contravened, or is likely to contravene, this Act or the regulations, the Minister may order the person to take any measures that the Minister considers necessary to remedy the contravention or prevent it.

  • Marginal note:Duty to take measures

    (2) A person that is ordered to take measures shall take them.

  • 2019, c. 29, s. 171
.

Analysis

Marginal note:Analysts

 The Minister may designate any individual as an analyst for the purposes of the administration and enforcement of this Act.

  • R.S., 1985, c. F-27, s. 28
  • 2016, c. 9, s. 6
.

Marginal note:Analysis and examination

  •  (1) An inspector may submit to an analyst, for analysis or examination, any article seized by the inspector, any sample therefrom or any sample taken by the inspector.

  • Marginal note:Costs

    (1.1) The analysis or examination of any article seized, or of any sample, shall be at the expense of

    • (a) in respect of an article seized or a sample taken from it, the owner of the article or the person having possession, care or control of the article at the time of its seizure; or

    • (b) in respect of a sample taken by the inspector, the owner of the article from which the sample was taken or the person having possession, care or control of it at the time the sample was taken.

  • Marginal note:Certificate or report

    (2) An analyst who has made an analysis or examination may issue a certificate or report setting out the results of the analysis or examination.

  • R.S., 1985, c. F-27, s. 29
  • 2016, c. 9, s. 7
.

Power of the Minister

Marginal note:List

  • 2012, c. 19, s. 413
.

 [Repealed, 2024, c. 17, s. 324]

Regulations

Marginal note:Regulations

  •  (1) The Governor in Council may make regulations for carrying the purposes and provisions of this Act into effect, and, in particular, but without restricting the generality of the foregoing, may make regulations

    • (a) declaring that any food or drug or class of food or drugs is adulterated if any prescribed substance or class of substances is present therein or has been added thereto or extracted or omitted therefrom;

    • (a.01) declaring that any drug is adulterated if the Minister believes that a prescribed substance contained in that drug presents a serious risk to the environment;

    • (a.1) respecting consultations in respect of orders referred to in section 2.4;

    • (b) respecting

      • (i) the labelling and packaging and the offering, exposing and advertising for sale of food, drugs, cosmetics and devices,

      • (ii) the size, dimensions, fill and other specifications of packages of food, drugs, cosmetics and devices,

      • (iii) the sale or the conditions of sale of any food, drug, cosmetic or device, and

      • (iv) the use of any substance as an ingredient in any food, drug, cosmetic or device,

      to prevent the purchaser or consumer thereof from being deceived or misled in respect of the design, construction, performance, intended use, quantity, character, value, composition, merit or safety thereof, or to prevent injury to the health of the purchaser or consumer;

    • (b.01) respecting, for the purposes of managing risks to the environment, any of the following:

      • (i) the labelling and packaging and the offering, exposing and advertising for sale of food, drugs, cosmetics and devices,

      • (ii) the size, dimensions, fill and other specifications of packages of food, drugs, cosmetics and devices,

      • (iii) the sale or the conditions of sale of any food, drug, cosmetic or device, and

      • (iv) the use of any substance as an ingredient in any food, drug, cosmetic or device;

    • (b.1) respecting the conduct of clinical trials;

    • (b.2) respecting the issuance of authorizations referred to in section 3.1 and the amendment, suspension and revocation of those authorizations;

    • (b.3) authorizing the Minister to impose terms and conditions on authorizations referred to in section 3.1, including existing authorizations, and to amend those terms and conditions;

    • (b.4) requiring the Minister to ensure that decisions with regard to the issuance, amendment, suspension and revocation of authorizations referred to in section 3.1, and to the imposition and amendment of terms and conditions referred to in paragraph (b.3), along with the reasons for those decisions, are publicly available;

    • (b.5) requiring holders of an authorization referred to in section 3.1, or former holders of such an authorization, to provide the Minister, after the clinical trial to which the authorization relates is completed or discontinued or, if the authorization is suspended or revoked, after the suspension or revocation, with safety information that the holders or former holders receive or become aware of about the drug, device or food for a special dietary purpose that is or was the subject of the clinical trial;

    • (c) prescribing standards of composition, strength, potency, purity, quality or other property of any article of food, drug, cosmetic or device;

    • (d) respecting the importation of food, drugs, cosmetics and devices — including any importation that is solely for the purpose of export — in order to ensure compliance with the provisions of this Act and the regulations;

    • (e) respecting the method of manufacture, preparation, preserving, packaging, storing and testing of any food, drug, cosmetic or device in the interest of, or for the prevention of injury to, the health of the purchaser or consumer or to manage risks to the environment;

    • (f) requiring persons that sell food, drugs, cosmetics or devices, or persons that import them solely for the purpose of export, to maintain any records, reports, electronic data or other documents that the Governor in Council considers necessary for the purposes of this Act;

    • (g) respecting the form and manner of the Minister’s indication under section 12, including the fees payable therefor, and prescribing what premises or what processes or conditions of manufacture, including qualifications of technical staff, shall or shall not be deemed to be suitable for the purposes of that section;

    • (h) requiring manufacturers of any drugs described in Schedule E to submit test portions of any batch of those drugs and respecting the form and manner of the Minister’s indication under section 13, including the fees payable therefor;

    • (h.01) respecting the provision to the Minister of evidence under subsection 16.3(2);

    • (h.1) respecting the establishment by the Minister of the list referred to in subsection 29.1(1), including amendments to it;

    • (i) respecting the powers, duties and functions of inspectors and analysts and the taking of samples;

    • (i.1) respecting the seizure, detention, forfeiture and disposition of articles under this Act;

    • (j) exempting, with or without conditions, any food, drug, cosmetic, device, person or activity from all or any of the provisions of this Act or the regulations;

    • (j.1) respecting orders referred to in sections 30.01, 30.02, 30.05 and 30.06;

    • (k) prescribing forms for the purposes of this Act and the regulations;

    • (k.1) respecting the time and manner in which information, notices and documents are to be provided or served under this Act;

    • (k.2) requiring persons to provide information to the Minister in respect of food, drugs, cosmetics or devices — or in respect of activities related to food, drugs, cosmetics or devices — in circumstances other than those provided for in this Act and authorizing the Minister to determine the information to be provided and the time and manner in which it is to be provided;

    • (l) providing for the analysis of food, drugs or cosmetics other than for the purposes of this Act and prescribing a tariff of fees to be paid for that analysis;

    • (l.1) respecting the assessment of the effect on the environment or on human life and health of the release into the environment of any food, drug, cosmetic or device, and the measures to take before importing or selling any such food, drug, cosmetic or device;

    • (m) adding anything to any of the schedules, other than to Schedule A or G, in the interest of, or for the prevention of injury to, the health of the purchaser or consumer, or deleting anything from any of the schedules, other than from Schedule A or G;

    • (n) respecting the distribution or the conditions of distribution of drugs as samples;

    • (o) respecting

      • (i) the method of manufacture, preparation, preserving, packing, labelling, storing and testing of any new drug, and

      • (ii) the sale or the conditions of sale of any new drug,

      and defining for the purposes of this Act the expression new drug;

    • (p) authorizing the advertising to the general public of contraceptive devices and drugs manufactured, sold or represented for use in the prevention of conception and prescribing the circumstances and conditions under which, and the persons by whom, those devices and drugs may be so advertised;

    • (q) defining agricultural chemical, food additive, mineral nutrient, veterinary drug and vitamin for the purposes of this Act;

    • (r) [Repealed, 2024, c. 17, s. 325]

    • (s) respecting the implementation, in relation to any food, drug, cosmetic or device, of international agreements that affect them; and

    • (t) prescribing anything that by this Act is to be prescribed.

  • Marginal note:Classes

    (1.1) A regulation made under this Act may establish classes and distinguish among those classes.

  • Marginal note:Regulations — therapeutic products

    (1.2) Without limiting the power conferred by any other subsection of this section, the Governor in Council may make regulations

    • (a) respecting the issuance of authorizations — including licences — that authorize, as the case may be, the import, sale, advertisement, manufacture, preparation, preservation, packaging, labelling, storage or testing of a therapeutic product, and the amendment, suspension and revocation of such authorizations;

    • (b) authorizing the Minister to impose terms and conditions on authorizations referred to in paragraph (a), including existing authorizations, and to amend those terms and conditions;

    • (b.1) requiring the Minister to ensure that decisions with regard to the issuance, amendment, suspension and revocation of authorizations referred to in paragraph (a), and to the imposition and amendment of terms and conditions in respect of those authorizations, along with the reasons for those decisions, are publicly available;

    • (b.2) specifying provisions of the regulations that are excluded from the exemption provided for in section 21.94 or 21.96;

    • (c) requiring holders of a therapeutic product authorization that authorizes the import or sale of a therapeutic product for a clinical trial, or former holders of such an authorization, to provide the Minister, after the trial is completed or discontinued, or, if the authorization is suspended or revoked, after the suspension or revocation, with safety information that the holders or former holders receive or become aware of about the therapeutic product;

    • (c.1) [Repealed, 2019, c. 29, s. 172]

    • (d) requiring holders of a therapeutic product authorization to provide the Minister with information, in respect of any serious risk of injury to human health, that the holders receive or become aware of and that is relevant to the safety of the therapeutic product to which the authorization relates, regarding

      • (i) risks that have been communicated outside Canada, and the manner of the communication,

      • (ii) changes that have taken place to labelling outside Canada, and

      • (iii) recalls, reassessments and suspensions or revocations of authorizations, including licences, in respect of a therapeutic product, that have taken place outside Canada;

    • (d.01) requiring holders of a therapeutic product authorization to provide the Minister with information, in respect of any serious risk to the environment, that the holders receive or become aware of and that is relevant to the therapeutic product to which the authorization relates, regarding

      • (i) risks that have been communicated outside Canada, and the manner of the communication,

      • (ii) changes that have taken place to labelling outside Canada, and

      • (iii) recalls, reassessments and suspensions or revocations of authorizations, including licences, in respect of a therapeutic product, that have taken place outside Canada;

    • (d.1) specifying the business information obtained under this Act in relation to an authorization under paragraph (a) that is not confidential business information, or the circumstances in which business information obtained under this Act in relation to such an authorization ceases to be confidential business information;

    • (d.2) authorizing the Minister to disclose, without notifying the person to whose business or affairs the information relates or obtaining their consent, business information that, under regulations made under paragraph (d.1),

      • (i) is not confidential business information, or

      • (ii) has ceased to be confidential business information;

    • (e) respecting modifications of labels and modifications and replacements of packages referred to in sections 21.2 and 21.302;

    • (f) respecting the recall of a therapeutic product or the sale of a therapeutic product that is the subject of a recall;

    • (f.1) respecting assessments referred to in section 21.31, and the provision of the results of the assessments to the Minister;

    • (f.2) requiring the Minister to ensure that decisions with regard to the making of orders under section 21.31, along with the reasons for those decisions, are publicly available;

    • (f.3) respecting the compilation of information, the conducting of tests and studies and the monitoring that are referred to in paragraphs 21.32(a) and 21.33(a), and the provision to the Minister of the information or results referred to in paragraphs 21.32(b) and 21.33(b);

    • (g) prescribing anything that is to be prescribed under section 21.71;

    • (h) defining serious adverse drug reaction and medical device incident for the purposes of this Act;

    • (i) respecting the provision by health care institutions referred to in section 21.8 to the Minister of information referred to in that section; and

    • (j) prescribing anything that is to be prescribed under section 21.8.

  • Marginal note:Consideration of existing information management systems

    (1.3) Before recommending to the Governor in Council that a regulation be made under paragraph (1.2)(i) or (j), the Minister shall take into account existing information management systems, with a view to not recommending the making of regulations that would impose unnecessary administrative burdens.

  • Marginal note:Regulations — preventing or alleviating shortages

    (1.4) Without limiting the power conferred by any other subsection of this section, the Governor in Council may make any regulations that the Governor in Council considers necessary for the purpose of preventing shortages of therapeutic products or foods for a special dietary purpose in Canada or alleviating those shortages or their effects, in order to protect human health.

  • Marginal note:Regulations — animal testing

    (1.5) Without limiting the power conferred by any other subsection of this section, the Governor in Council may make any regulations that the Governor in Council considers necessary for the purpose of preventing, in respect of cosmetics, the conduct of a test on an animal that could cause pain, suffering or injury, whether physical or mental, to the animal, or preventing the purchaser or consumer of a cosmetic from being deceived or misled in respect of whether the cosmetic was tested on animals.

  • Marginal note:Regulations respecting drugs manufactured outside Canada

    (2) Without limiting the power conferred by any other subsection of this section, the Governor in Council may make such regulations governing, regulating or prohibiting

    • (a) the importation into Canada of any drug or class of drugs manufactured outside Canada, or

    • (b) the distribution or sale in Canada, or the offering, exposing or having in possession for sale in Canada, of any drug or class of drugs manufactured outside Canada,

    as the Governor in Council deems necessary for the protection of the public in relation to the safety and quality of any such drug or class of drugs.

  • Marginal note:Regulations — Canada–United States–Mexico Agreement and WTO Agreement

    (3) Without limiting the power conferred by any other subsection of this section, the Governor in Council may make any regulations that the Governor in Council considers necessary for the purpose of implementing, in relation to drugs, Articles 20.48 and 20.49 of the Canada–United States–Mexico Agreement or paragraph 3 of Article 39 of the Agreement on Trade-related Aspects of Intellectual Property Rights set out in Annex 1C to the WTO Agreement.

  • Marginal note:Definitions

    (4) In subsection (3),

    Canada–United States–Mexico Agreement

    Canada–United States–Mexico Agreement has the meaning assigned by the definition Agreement in section 2 of the Canada–United States–Mexico Agreement Implementation Act; (Accord Canada–États-Unis–Mexique)

    North American Free Trade Agreement

    North American Free Trade Agreement[Repealed, 2020, c. 1, s. 58]

    WTO Agreement

    WTO Agreement has the meaning given to the word Agreement by subsection 2(1) of the World Trade Organization Agreement Implementation Act. (Accord sur l’OMC)

  • Marginal note:Regulations to implement General Council Decision

    (5) Without limiting the power conferred by any other subsection of this section, the Governor in Council may make any regulations that the Governor in Council considers necessary for the purpose of implementing the General Council Decision.

  • Marginal note:Definitions

    (6) The definitions in this subsection apply in this subsection and in subsection (5).

    General Council

    General Council means the General Council of the WTO established by paragraph 2 of Article IV of the Agreement Establishing the World Trade Organization, signed at Marrakesh on April 15, 1994. (Conseil général)

    General Council Decision

    General Council Decision means the decision of the General Council of August 30, 2003 respecting Article 31 of the TRIPS Agreement, including the interpretation of that decision in the General Council Chairperson’s statement of that date. (décision du Conseil général)

    TRIPS Agreement

    TRIPS Agreement means the Agreement on Trade-Related Aspects of Intellectual Property Rights, being Annex 1C of the Agreement Establishing the World Trade Organization, signed at Marrakesh on April 15, 1994. (Accord sur les ADPIC)

    WTO

    WTO means the World Trade Organization established by Article I of the Agreement Establishing the World Trade Organization, signed at Marrakesh on April 15, 1994. (OMC)

  • R.S., 1985, c. F-27, s. 30
  • 1993, c. 44, s. 158
  • 1994, c. 47, s. 117
  • 1999, c. 33, s. 347
  • 2004, c. 23, s. 2
  • 2005, c. 42, s. 2
  • 2012, c. 19, ss. 414, 415
  • 2014, c. 24, ss. 6, 14(E)
  • 2016, c. 9, s. 8
  • 2019, c. 29, s. 172
  • 2020, c. 1, s. 58
  • 2020, c. 5, s. 33
  • 2021, c. 7, s. 9
  • 2023, c. 12, s. 67
  • 2023, c. 26, s. 506
  • 2024, c. 17, s. 325
.

Supplementary Rules

Marginal note:Supplementary rules — therapeutic product

  •  (1) Subject to any regulations made under paragraph 30(1)(j.1) and if the Minister believes on reasonable grounds that the use of a therapeutic product, other than the intended use, may present a risk of injury to health, the Minister may, by order, establish rules in respect of the importation, sale, conditions of sale, advertising, manufacture, preparation, preservation, packaging, labelling, storage or testing of the therapeutic product for the purpose of preventing, managing or controlling the risk of injury to health.

  • Marginal note:Promotion

    (2) For greater certainty, the Minister may, in the order, establish rules for the purpose of preventing the therapeutic product from being promoted for a use, other than the intended use, of a therapeutic product or preventing a use, other than the intended use, of a therapeutic product from being appealing.

  • Marginal note:Uncertainty

    (3) The Minister may make the order despite any uncertainty respecting the risk of injury to health that the use of the therapeutic product, other than the intended use, may present.

  • 2024, c. 17, s. 326
.

Marginal note:Supplementary rules — drug intended for animal

  •  (1) Subject to any regulations made under paragraph 30(1)(j.1) and if the Minister believes on reasonable grounds that the use of a drug intended for an animal of a particular species, including a use other than the intended use, may present a risk of adverse effects to human beings, animals of a different species or the environment, the Minister may, by order, establish rules in respect of the importation, sale, conditions of sale, advertising, manufacture, preparation, preservation, packaging, labelling, storage or testing of the drug for the purpose of preventing, managing or controlling the risk of adverse effects.

  • Marginal note:Uncertainty

    (2) The Minister may make the order despite any uncertainty respecting the risk of adverse effects that the use of the drug, including a use other than the intended use, may present.

  • 2024, c. 17, s. 326
.

Marginal note:Availability — person-specific orders

 The Minister must ensure that any order made under subsection 30.01(1) or 30.02(1) that applies to only one person is publicly available but may exclude personal information and confidential business information from the order.

  • 2024, c. 17, s. 326
.

Exemption

Marginal note:Exemption — foods and therapeutic products

  •  (1) Subject to subsection (2) and any regulations made under paragraph 30(1)(j.1), the Minister may, by order, on any conditions that the Minister considers necessary, exempt — other than in relation to cosmetics — a class of foods, therapeutic products, persons or activities from the application of all or any of the provisions of Part I, section 37 or the regulations.

  • Marginal note:Preconditions

    (2) The Minister may make an order only if the Minister believes on reasonable grounds that

    • (a) it is necessary for a health or safety purpose or is otherwise in the public interest; and

    • (b) having regard to its benefits and conditions, it is unlikely to result in

      • (i) unacceptable health, safety or, if applicable, environmental risks, or

      • (ii) an unacceptable degree of uncertainty respecting health, safety or, if applicable, environmental risks.

  • Marginal note:Obligation to comply with conditions

    (3) Any person to whom a condition applies must comply with that condition.

  • 2024, c. 17, s. 326
.

Decision of Foreign Regulatory Authority

Marginal note:Deeming order

  •  (1) Subject to subsection (2) and any regulations made under paragraph 30(1)(j.1), the Minister may, by order, deem that specified requirements of this Act or the regulations are met — in respect of a therapeutic product or food that belongs to a class specified in the order — on the basis of a decision of, or any information or document produced by, a foreign regulatory authority in respect of that therapeutic product or food.

  • Marginal note:Preconditions

    (2) The Minister may make the order only if the Minister believes on reasonable grounds that

    • (a) it is necessary for a health or safety purpose or is otherwise in the public interest; and

    • (b) having regard to its benefits and conditions, it is unlikely to result in

      • (i) unacceptable health, safety or, if applicable, environmental risks, or

      • (ii) an unacceptable degree of uncertainty respecting health, safety or, if applicable, environmental risks.

  • Marginal note:Power to impose conditions

    (3) The Minister may, in the order, impose any conditions that the Minister considers necessary.

  • Marginal note:Obligation to comply with conditions

    (4) Any person to whom a condition applies must comply with that condition.

  • Marginal note:Clarifications

    (5) For greater certainty,

    • (a) the requirements referred to in subsection (1) include requirements imposed on the Minister;

    • (b) the Minister may rely on a portion of a decision of, or a portion of any document or information produced by, a foreign regulatory authority; and

    • (c) nothing in this section is intended to limit the Minister’s ability to consider information, documents or other material obtained, directly or indirectly, from a foreign regulatory authority.

  • 2024, c. 17, s. 328
.

Reference to Regulations

Marginal note:Deeming

 For the purposes of any provision of this Act, other than sections 30.01, 30.02, 30.05 and 30.06, any reference to regulations made under this Act is deemed to include orders made under section 30.01, 30.02, 30.05 or 30.06.

  • 2024, c. 17, s. 328
.

Interim Orders

Marginal note:Interim orders

  •  (1) The Minister may make an interim order that contains any provision that may be contained in a regulation made under this Act if the Minister believes that immediate action is required to deal with a significant risk, direct or indirect, to health, safety or the environment.

  • Marginal note:Cessation of effect

    (2) An interim order has effect from the time that it is made but ceases to have effect on the earliest of

    • (a) 14 days after it is made, unless it is approved by the Governor in Council,

    • (b) the day on which it is repealed,

    • (c) the day on which a regulation made under this Act, that has the same effect as the interim order, comes into force, and

    • (d) one year after the interim order is made or any shorter period that may be specified in the interim order.

  • Marginal note:Contravention of unpublished order

    (3) No person shall be convicted of an offence consisting of a contravention of an interim order that, at the time of the alleged contravention, had not been published in the Canada Gazette unless it is proved that, at the time of the alleged contravention, the person had been notified of the interim order or reasonable steps had been taken to bring the purport of the interim order to the notice of those persons likely to be affected by it.

  • Marginal note:Exemption from Statutory Instruments Act

    (4) An interim order

  • Marginal note:Deeming

    (5) For the purpose of any provision of this Act other than this section and section 30.05, any reference to regulations made under this Act is deemed to include interim orders, and any reference to a regulation made under a specified provision of this Act is deemed to include a reference to the portion of an interim order containing any provision that may be contained in a regulation made under the specified provision.

  • Marginal note:Tabling of order

    (6) A copy of each interim order must be tabled in each House of Parliament within 15 days after it is made.

  • Marginal note:House not sitting

    (7) In order to comply with subsection (6), the interim order may be sent to the Clerk of the House if the House is not sitting.

  • 2004, c. 15, s. 66
  • 2024, c. 17, s. 329
.

 [Repealed, 2024, c. 17, s. 330]

 [Repealed, 2024, c. 17, s. 330]

 [Repealed, 2024, c. 17, s. 330]

Incorporation by Reference

Marginal note:Incorporation by reference

  •  (1) A regulation made under this Act with respect to a food or therapeutic product and an order made under subsection 30.63(1) may incorporate by reference any document, regardless of its source, either as it exists on a particular date or as it is amended from time to time.

  • Marginal note:Accessibility of incorporated documents

    (2) The Minister shall ensure that any document that is incorporated by reference is accessible.

  • Marginal note:Defence

    (3) A person is not liable to be found guilty of an offence for any contravention in respect of which a document that is incorporated by reference is relevant unless, at the time of the alleged contravention, the document was accessible as required by subsection (2) or it was otherwise accessible to the person.

  • Marginal note:No registration or publication

    (4) For greater certainty, a document that is incorporated by reference is not required to be transmitted for registration or published in the Canada Gazette by reason only that it is incorporated by reference.

  • 2012, c. 19, s. 416
  • 2014, c. 24, s. 7
  • 2024, c. 17, s. 331
.

Marginal note:Existing power not limited

 For greater certainty, an express power in this Act to incorporate a document by reference does not limit the power that otherwise exists to incorporate a document by reference in a regulation made under this Act.

  • 2012, c. 19, s. 416
.

Fees

Marginal note:Fees

  •  (1) The Minister may, by order, fix the following fees in relation to a drug, device, food or cosmetic:

    • (a) fees to be paid for a service, or the use of a facility, provided under this Act;

    • (b) fees to be paid in respect of regulatory processes or approvals provided under this Act; and

    • (c) fees to be paid in respect of products, rights and privileges provided under this Act.

  • Marginal note:Amount not to exceed cost

    (2) A fee fixed under paragraph (1)(a) may not exceed the cost to Her Majesty in right of Canada of providing the service or the use of the facility.

  • Marginal note:Aggregate amount not to exceed cost

    (3) Fees fixed under paragraph (1)(b) may not in the aggregate exceed the cost to Her Majesty in right of Canada in respect of providing the regulatory processes or approvals.

  • 2017, c. 20, s. 317
.

Marginal note:Consultation

 Before making an order under subsection 30.61(1), the Minister shall consult with any persons that the Minister considers to be interested in the matter.

  • 2017, c. 20, s. 317
.

Marginal note:Remission of fees

  •  (1) The Minister may, by order, remit all or part of any fee fixed under subsection 30.61(1) and the interest on it.

  • Marginal note:Remission may be conditional

    (2) A remission granted under subsection (1) may be conditional.

  • Marginal note:Conditional remission

    (3) If a remission granted under subsection (1) is conditional and the condition is not fulfilled, then the remission is cancelled and is deemed never to have been granted.

  • 2017, c. 20, s. 317
.

Marginal note:Non-payment of fees

 The Minister may withdraw or withhold a service, the use of a facility, a regulatory process or approval or a product, right or privilege under this Act from any person who fails to pay the fee fixed for it under subsection 30.61(1).

  • 2017, c. 20, s. 317
.

Marginal note:Adjustment of amounts

  •  (1) An order made under subsection 30.61(1) may prescribe rules for the adjustment of the amount of the fee by any amounts or ratios that are referred to in the order, for the period that is specified in the order.

  • Marginal note:Notice of adjusted amount

    (2) The amount of a fee that is subject to an adjustment rule remains unadjusted for the specified period unless, before the beginning of that period, the Minister publishes a notice in the Canada Gazette that specifies the adjusted amount and the manner in which it was determined.

  • 2017, c. 20, s. 317
.

Costs

Marginal note:Recovery

  •  (1) Her Majesty in right of Canada may recover, as a debt due to Her Majesty in right of Canada, any costs incurred by Her Majesty in right of Canada in relation to anything required or authorized under this Act, including the inspection of a place or the analysis, examination, storage, movement, seizure, detention, forfeiture, disposal or release of an article.

  • Marginal note:Time limit

    (2) Proceedings to recover a debt due to Her Majesty in right of Canada under subsection (1) shall not be commenced later than five years after the debt became payable.

  • 2016, c. 9, s. 9
.

Marginal note:Certificate of default

  •  (1) Any debt that may be recovered under subsection 30.7(1) in respect of which there is a default of payment, or the part of any such debt that has not been paid, may be certified by the Minister.

  • Marginal note:Judgment

    (2) On production to the Federal Court, a certificate made under subsection (1) shall be registered in that Court and, when registered, has the same force and effect, and all proceedings may be taken on the certificate, as if it were a judgment obtained in that Court for a debt of the amount specified in the certificate and all reasonable costs and charges attendant in the registration of the certificate.

  • 2016, c. 9, s. 9
.

Offences and Punishment

Marginal note:Contravention of Act or regulations

 Subject to sections 31.1, 31.2 and 31.4, every person who contravenes any of the provisions of this Act or of the regulations, or fails to do anything the person was ordered to do by an inspector under section 25 or 27.2, is guilty of an offence and liable

  • (a) on summary conviction for a first offence to a fine not exceeding five hundred dollars or to imprisonment for a term not exceeding three months or to both and, for a subsequent offence, to a fine not exceeding one thousand dollars or to imprisonment for a term not exceeding six months or to both; and

  • (b) on conviction on indictment to a fine not exceeding five thousand dollars or to imprisonment for a term not exceeding three years or to both.

  • R.S., 1985, c. F-27, s. 31
  • 1996, c. 19, s. 77
  • 1997, c. 6, ss. 65, 91
  • 2014, c. 24, s. 8
  • 2016, c. 9, s. 10
.

Marginal note:Offences relating to food

  •  (1) Every person who contravenes any provision of this Act or the regulations, as it relates to food, is guilty of an offence and liable

    • (a) on summary conviction, to a fine not exceeding $50,000 or to imprisonment for a term not exceeding six months or to both; or

    • (b) on conviction by indictment, to a fine not exceeding $250,000 or to imprisonment for a term not exceeding three years or to both.

  • Marginal note:Clarification

    (2) For greater certainty, subsection (1) applies in respect of the following provisions of this Act:

    • (a) section 3, if the contravention of that section involves food;

    • (a.1) section 3.1 or 3.3, if the contravention of that section involves a clinical trial that relates to food;

    • (a.2) section 3.2, if the contravention of that section involves the terms and conditions of an authorization that authorizes the conduct of a clinical trial that relates to food;

    • (b) subsection 22.1(2), if the contravention of that subsection involves any document or information that relates to food or a sample that is or relates to food;

    • (c) subsection 23(6), if the contravention of that subsection involves a conveyance in respect of which an inspector is exercising powers or performing duties or functions in relation to food;

    • (d) subsection 23(13), if the contravention of that subsection involves a place in which an inspector is exercising powers or performing duties or functions in relation to food;

    • (e) subsection 24(1), if the contravention of that subsection involves the obstruction or hindering of — or the making of a false or misleading statement to — an inspector who is carrying out duties or functions in relation to food;

    • (f) subsection 24(2), if the contravention of that subsection involves anything seized that is or relates to food; and

    • (g) subsection 27.3(2), if the contravention of that subsection involves measures that were ordered to be taken in relation to food.

  • 1997, c. 6, s. 66
  • 2019, c. 29, s. 173
.

Marginal note:Offences relating to therapeutic products

  •  (1) Subject to section 31.4, every person who contravenes any provision of this Act or the regulations, as it relates to a therapeutic product, or an order made under any of sections 21.1 to 21.32 is guilty of an offence and liable

    • (a) on conviction by indictment, to a fine not exceeding $5,000,000 or to imprisonment for a term not exceeding two years or to both; and

    • (b) on summary conviction, for a first offence, to a fine not exceeding $250,000 or to imprisonment for a term not exceeding six months or to both and, for a subsequent offence, to a fine not exceeding $500,000 or to imprisonment for a term not exceeding 18 months or to both.

  • Marginal note:Clarification

    (2) For greater certainty, subsection (1) applies in respect of the following provisions of this Act:

    • (a) section 3, if the contravention of that section involves a therapeutic product;

    • (a.1) section 3.1 or 3.3, if the contravention of that section involves a clinical trial that relates to a therapeutic product;

    • (a.2) section 3.2, if the contravention of that section involves the terms and conditions of an authorization that authorizes the conduct of a clinical trial that relates to a therapeutic product;

    • (b) subsection 22.1(2), if the contravention of that subsection involves any document or information that relates to a therapeutic product or a sample that is or relates to a therapeutic product;

    • (c) subsection 23(6), if the contravention of that subsection involves a conveyance in respect of which an inspector is exercising powers or performing duties or functions in relation to a therapeutic product;

    • (d) subsection 23(13), if the contravention of that subsection involves a place in which an inspector is exercising powers or performing duties or functions in relation to a therapeutic product;

    • (e) subsection 24(1), if the contravention of that subsection involves the obstruction or hindering of — or the making of a false or misleading statement to — an inspector who is carrying out duties or functions in relation to a therapeutic product;

    • (f) subsection 24(2), if the contravention of that subsection involves anything seized that is or relates to a therapeutic product; and

    • (g) subsection 27.3(2), if the contravention of that subsection involves measures that were ordered to be taken in relation to a therapeutic product.

  • 2014, c. 24, ss. 9, 10
  • 2019, c. 29, s. 174
.

Marginal note:Due diligence

 Due diligence is a defence in a prosecution for an offence under this Act, other than an offence under section 31.4.

  • 2014, c. 24, s. 9
.

Marginal note:Offences — section 21.6 and serious risk

  •  (1) A person who contravenes section 21.6, or who knowingly or recklessly causes a serious risk of injury to human health in contravening another provision of this Act or the regulations, as it relates to a therapeutic product, or an order made under any of sections 21.1 to 21.32 is guilty of an offence and liable

    • (a) on conviction on indictment, to a fine the amount of which is at the discretion of the court or to imprisonment for a term not exceeding five years or to both; and

    • (b) on summary conviction, for a first offence, to a fine not exceeding $500,000 or to imprisonment for a term not exceeding 18 months or to both and, for a subsequent offence, to a fine not exceeding $1,000,000 or to imprisonment for a term not exceeding two years or to both.

  • Marginal note:Clarification

    (2) For greater certainty, subsection (1) applies in respect of the following provisions of this Act:

    • (a) section 3, if the contravention of that section involves a therapeutic product;

    • (a.1) section 3.1, if the contravention of that section involves a clinical trial that relates to a therapeutic product;

    • (a.2) section 3.2, if the contravention of that section involves the terms and conditions of an authorization that authorizes the conduct of a clinical trial that relates to a therapeutic product;

    • (b) subsection 22.1(2), if the contravention of that subsection involves any document or information that relates to a therapeutic product or a sample that is or relates to a therapeutic product;

    • (c) subsection 23(6), if the contravention of that subsection involves a conveyance in respect of which an inspector is exercising powers or performing duties or functions in relation to a therapeutic product;

    • (d) subsection 23(13), if the contravention of that subsection involves a place in which an inspector is exercising powers or performing duties or functions in relation to a therapeutic product;

    • (e) subsection 24(1), if the contravention of that subsection involves the obstruction or hindering of — or the making of a false or misleading statement to — an inspector who is carrying out duties or functions in relation to a therapeutic product;

    • (f) subsection 24(2), if the contravention of that subsection involves anything seized that is or relates to a therapeutic product; and

    • (g) subsection 27.3(2), if the contravention of that subsection involves measures that were ordered to be taken in relation to a therapeutic product.

  • 2014, c. 24, ss. 9, 11
  • 2019, c. 29, s. 175
.

Marginal note:Sentencing considerations

 A court that imposes a sentence for an offence under section 31.2 or 31.4 shall take into account, in addition to any other principles that it is required to consider, the following factors:

  • (a) the harm or risk of harm caused by the commission of the offence; and

  • (b) the vulnerability of consumers of the therapeutic product.

  • 2014, c. 24, s. 9
.

Marginal note:Parties to offence

 If a person other than an individual commits an offence under section 31.2, or commits an offence under section 31.4 by reason of contravening section 21.6, then any of the person’s directors, officers or agents or mandataries who directs, authorizes, assents to or acquiesces or participates in the commission of the offence is a party to the offence and is liable on conviction to the punishment provided for by this Act, even if the person is not prosecuted for the offence.

  • 2014, c. 24, s. 9
.

Marginal note:Continuing offence

 If an offence under section 31.2 or 31.4 is committed or continued on more than one day, it constitutes a separate offence for each day on which it is committed or continued.

  • 2014, c. 24, s. 9
.

Marginal note:Limitation period

  •  (1) A prosecution for a summary conviction offence under this Act may be instituted at any time within two years after the time the subject-matter of the prosecution becomes known to the Minister or, in the case of a contravention of a provision of the Act that relates to food, to the Minister of Agriculture and Agri-Food.

  • Marginal note:Minister’s certificate

    (2) A document purporting to have been issued by the Minister referred to in subsection (1), certifying the day on which the subject-matter of any prosecution became known to the Minister, is admissible in evidence without proof of the signature or official character of the person appearing to have signed the document and is evidence of the matters asserted in it.

  • R.S., 1985, c. F-27, s. 32
  • 1997, c. 6, s. 66
.

Marginal note:Venue

 A prosecution for a contravention of this Act or the regulations may be instituted, heard, tried or determined in the place in which the offence was committed or the subject-matter of the prosecution arose or in any place in which the accused is apprehended or happens to be.

  • R.S., c. F-27, s. 28
.

Marginal note:Want of knowledge

  •  (1) Subject to subsection (2), in a prosecution for the sale of any article in contravention of this Act, except Parts III and IV, or of the regulations made under this Part, if the accused proves to the satisfaction of the court or judge that

    • (a) the accused purchased the article from another person in packaged form and sold it in the same package and in the same condition the article was in at the time it was so purchased, and

    • (b) that the accused could not with reasonable diligence have ascertained that the sale of the article would be in contravention of this Act or the regulations,

    the accused shall be acquitted.

  • Marginal note:Notice of reliance on want of knowledge

    (2) Subsection (1) does not apply in any prosecution unless the accused, at least ten days before the day fixed for the trial, has given to the prosecutor notice in writing that the accused intends to avail himself of the provisions of subsection (1) and has disclosed to the prosecutor the name and address of the person from whom the accused purchased the article and the date of purchase.

  • R.S., c. F-27, ss. 29, 39, 46
.

Marginal note:Certificate of analyst

  •  (1) Subject to this section, in any prosecution for an offence under any of sections 31 to 31.2 and 31.4, a certificate purporting to be signed by an analyst and stating that an article, sample or substance has been submitted to, and analysed or examined by, the analyst and stating the results of the analysis or examination is admissible in evidence and, in the absence of evidence to the contrary, is proof of the statements contained in the certificate without proof of the signature or official character of the person appearing to have signed it.

  • Marginal note:Requiring attendance of analyst

    (2) The party against whom a certificate of an analyst is produced pursuant to subsection (1) may, with leave of the court, require the attendance of the analyst for the purposes of cross-examination.

  • Marginal note:Notice of intention to produce certificate

    (3) No certificate shall be admitted in evidence pursuant to subsection (1) unless, before the trial, the party intending to produce the certificate has given reasonable notice of that intention, together with a copy of the certificate, to the party against whom it is intended to be produced.

  • Marginal note:Proof of service

    (4) For the purposes of this Act, service of any certificate referred to in subsection (1) may be proved by oral evidence given under oath by, or by the affidavit or solemn declaration of, the person claiming to have served it.

  • Marginal note:Attendance for examination

    (5) Notwithstanding subsection (4), the court may require the person who appears to have signed an affidavit or solemn declaration referred to in that subsection to appear before it for examination or cross-examination in respect of the issue of proof of service.

  • R.S., 1985, c. F-27, s. 35
  • R.S., 1985, c. 27 (1st Supp.), s. 192
  • 1996, c. 19, s. 78
  • 2014, c. 24, s. 12
.

Marginal note:Proof as to manufacturer or packager

  •  (1) In a prosecution for a contravention of this Act or of the regulations made under this Part, proof that a package containing any article to which this Act or the regulations apply bore a name or address purporting to be the name or address of the person by whom it was manufactured or packaged is, in the absence of evidence to the contrary, proof that the article was manufactured or packaged, as the case may be, by the person whose name or address appeared on the package.

  • Marginal note:Offence by employee or agent

    (2) In a prosecution for a contravention described in subsection (1), it is sufficient proof of the offence to establish that it was committed by an employee or agent of the accused whether or not the employee or agent is identified or has been prosecuted for the offence.

  • Marginal note:Certified copies

    (3) In a prosecution for a contravention described in subsection (1), a copy of or extract from a document, including electronic data, that is certified to be a true copy by the inspector who made or took it under paragraph 23(2)(c), (d) or (f), as the case may be, is admissible in evidence and is, in the absence of evidence to the contrary, proof of its contents.

  • Marginal note:Where accused had adulterating substances

    (4) Where a person is prosecuted under this Part for having manufactured an adulterated food or drug for sale, and it is established that the person had in his possession or on his premises any substance the addition of which to that food or drug has been declared by regulation to cause the adulteration of the food or drug, the onus of proving that the food or drug was not adulterated by the addition of that substance lies on the accused.

  • R.S., 1985, c. F-27, s. 36
  • 1996, c. 19, s. 79
  • 2019, c. 29, s. 176
.

Exports

Marginal note:Conditions under which exports exempt

  •  (1) This Act does not apply to any packaged food, drug, cosmetic or device if

    • (a) it is manufactured or prepared in Canada;

    • (b) it is intended for export and is not manufactured or prepared for consumption or use in Canada nor sold for consumption or use in Canada;

    • (c) a certificate that the package and its contents do not contravene any known requirement of the law of the country to which it is or is about to be consigned has been issued in respect of the package and its contents in prescribed form and manner; and

    • (d) the packaged food, drug, cosmetic or device meets any other prescribed requirement.

  • Marginal note:Exception — Act

    (1.1) Despite subsection (1),

  • Marginal note:Exception — regulations

    (1.2) Despite subsection (1), any prescribed provision of the regulations applies to any food, drug, cosmetic or device.

  • Marginal note:Exception — General Council Decision

    (2) Despite subsection (1), this Act applies in respect of any drug or device to be manufactured for the purpose of being exported in accordance with the General Council Decision, as defined in subsection 30(6), and the requirements of the Act and the regulations apply to the drug or device as though it were a drug or device to be manufactured and sold for consumption or use in Canada, unless the regulations provide otherwise.

  • R.S., 1985, c. F-27, s. 37
  • 1993, c. 34, s. 73
  • 1996, c. 19, s. 80
  • 2004, c. 23, s. 3
  • 2016, c. 9, s. 11
  • 2020, c. 5, s. 34
  • 2021, c. 7, s. 10
.

Marginal note:Conditions under which transhipment exempt

 This Act does not apply to any packaged food, drug, cosmetic or device if

  • (a) it is manufactured or prepared outside Canada;

  • (b) it is imported solely for the purpose of export and is not sold for consumption or use in Canada; and

  • (c) it meets any other prescribed requirement.

  • 2016, c. 9, s. 12
.
Loading…